← Eichor
Condition: Oncology Patients Receiving Chemotherapy Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Oncology Patients Receiving Chemotherapy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemothera
NA · 1 location(s) · Dana-Farber Cancer Institute · NCT04997096Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indi
NA · 1 location(s) · St. Jude Children's Research Hospital · NCT04764357A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensi
Phase N/A · 13 location(s) · AbbVie · NCT05317494An Observational Study to Evaluate Neoadjuvant Nivolumab (OPDIVO®) in Combination With Platinum-Based Chemotherapy in No
Phase N/A · 1 location(s) · Bristol-Myers Squibb · NCT06169956Localized Leiomyosarcoma Biomarker Protocol
Phase N/A · 3 location(s) · University of Michigan Rogel Cancer Center · NCT04925089Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy
Phase N/A · 3 location(s) · Mayo Clinic · NCT06279572Children's Laughter and Fun Yoga as Adjunctive Pain Relief Following Chemotherapy.
NA · 1 location(s) · Bahaa Bou Dargham · NCT07327138Efficacy and Safety of Non Invasive Vagal Stimulation to Prevent Chemotherapy-induced Nausea
NA · 8 location(s) · University Hospital, Tours · NCT04937309Nutritional Supplementation in Head and Neck Cancers
Phase 2 · 1 location(s) · AHS Cancer Control Alberta · NCT05379712Andamertinib With or Without Platinum-doublet Chemotherapy Versus Platinum-doublet Chemotherapy in Patients With NSCLC H
Phase 2 · 1 location(s) · Avistone Biotechnology Co., Ltd. · NCT07336732Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma
Phase 3 · 1 location(s) · Shanghai Kechow Pharma, Inc. · NCT06008106Pilot Study to Evaluate Targeted Physical Activity Among Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy
NA · 1 location(s) · University of Illinois at Chicago · NCT07647250Feasibility of a Preoperative, Multimodal Lifestyle Intervention in Patients With Breastcancer
NA · 1 location(s) · Maastricht University Medical Center · NCT06266312Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer
Phase 2 · 4 location(s) · University of Chicago · NCT06291064Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan
Phase 3 · 1 location(s) · Augusta University · NCT06588413Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT
Phase 1/Phase 2 · 1 location(s) · University of California, Irvine · NCT04520139Neoadjuvant Breast Cancer Time Restricted Eating
NA · 1 location(s) · Thomas Jefferson University · NCT05327608Impact of an Early Warning System on the Prognosis of Patients With Hematological Malignancies Receiving Intensive Chemo
NA · 10 location(s) · University Hospital, Angers · NCT06409767Dynamic Prediction Model for Patients with Unresectable Biliary Malignancies Receiving Systemic Chemotherapy Combined wi
Phase N/A · 2 location(s) · Zhongda Hospital · NCT06849193Olanzapine in the Prevention and Treatment of Anorexia-Cachexia Syndrome in Patients Receiving Neoadjuvant/Preoperative
Phase 3 · 1 location(s) · Blokhin's Russian Cancer Research Center · NCT07633236Metastatic Leiomyosarcoma Biomarker Protocol
Phase N/A · 11 location(s) · University of Michigan Rogel Cancer Center · NCT05653388ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies
Phase N/A · 1 location(s) · University Hospital, Caen · NCT07191730Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro
Phase 2 · 1 location(s) · University of Alabama at Birmingham · NCT05952453Systemic Chemotherapy With FOLFOX Plus Atezolizumab & Bevacizumab for Patients With Advanced HCC Who Previously Received
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07192185A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Parti
Phase 1/Phase 2 · 32 location(s) · Regeneron Pharmaceuticals · NCT05828511Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
Phase 2 · 1 location(s) · University of California, Irvine · NCT07447050PROtein, Leucine and Vitamin D Supplementation In Patients With GYnecologic Cancer Receiving Platinum-based Chemotherapy
NA · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT06087783Proof of Concept to Assess the Feasibility of a Decentralised Pathway Coordinated by the Advanced Practice Nurse for Pat
NA · 1 location(s) · Institut Claudius Regaud · NCT06797037Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients
Phase 2 · 1 location(s) · Wake Forest University Health Sciences · NCT04677816Frailty Assessment and Intervention in Elderly Patients with Gastric Cancer Receiving Gastrectomy and Adjuvant Chemother
NA · 1 location(s) · Chang Gung Memorial Hospital · NCT06055387
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.